Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 27.07.2021 at 12:00 PM CEST
Settings

Settings

Goto Application

1. WO2020084435 - PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO

WO/2020/084435PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO
Appl.Date 21.10.2019
Appl.No PCT/IB2019/058940 Applicant PFIZER INC. Pub.Kind A Pub.Lang en
Inclusion Criteria IC1
PCT application from which the family originated.
Pub.Date 30.04.2020
AU2019363840Pyrrolo(2,3-d)pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto
Appl.Date 21.10.2019
Appl.No 2019363840 Applicant Pfizer Inc. Pub.Kind A,A1
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.04.2020
SG11202103667QPYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO
Appl.Date 21.10.2019
Appl.No 11202103667Q Applicant PFIZER INC. Pub.Kind A1
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 28.05.2021
CN112888691吡咯并[2,3-d]嘧啶甲苯磺酸盐、其结晶形式以及有关的制备方法和中间体
Appl.Date 21.10.2019
Appl.No 201980069164.0 Applicant 辉瑞公司 Pub.Kind A
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 01.06.2021
KR1020210080468피롤로[2,3-d]피리미딘 토실레이트 염, 이의 결정질 형태, 이의 제조 방법 및 이에 대한 중간체
Appl.Date 21.10.2019
Appl.No 1020217015125 Applicant 화이자 인코포레이티드 Pub.Kind A
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.06.2021
MXMX/a/2021/003241
Appl.Date 18.03.2021
Appl.No MX/a/2021/003241
Inclusion Criteria IC3
National entry of a PCT application not found in PATENTSCOPE.
IL282446PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO
Appl.Date 19.04.2021
Appl.No 282446 Applicant PFIZER INC. Pub.Kind A Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.06.2021
NZ775210PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO
Appl.Date 20.04.2021
Appl.No 775210 Applicant PFIZER INC. Pub.Kind A Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.04.2021
RU2021109514
Appl.Date 24.05.2021
Appl.No 2021109514
Inclusion Criteria IC3
National entry of a PCT application not found in PATENTSCOPE.
EP2019794259
Appl.Date 25.05.2021
Appl.No 2019794259
Inclusion Criteria IC3
National entry of a PCT application not found in PATENTSCOPE.